Picture Kentro Design Is Key to Your Success Berlin 650x100px

Person › Details

Martin Bonde (Vaccibody AS (Euronext Growth Oslo: VACC))

Bonde, Martin (Vaccibody 201508– CEO before EpiTherapeutics ApS + Aros Pharma ApS + Natimmune AS + Combio AS)

	Organisation	Vaccibody AS (Euronext Growth Oslo: VACC)
	Today	Nykode Therapeutics AS (Euronext Growth Oslo: NYKD)
	Former/major organisation	EpiTherapeutics ApS
	Group	Gilead Sciences Inc. (Nasdaq: GILD)
	Product	vaccine
	Product 2	cancer drug

Record changed: 2021-01-02

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Martin Bonde

[1] Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]